This site is intended for health professionals only

At the heart of general practice since 1960

I don't have time to follow CKD script advice

I was interested in the letter from Dr Donal O'Donoghue (3 October) on prescribing safety in kidney patients.

I wonder whether, as national clinical director for kidney care, he could direct me to a dependable source of information on which drugs need dose modification in renal impairment, haemodialysis and peritoneal dialysis.

Both I and our local pharmaceutical adviser have searched in vain: even the haemodialysis unit and local nephrology department were unable to help.

Each drug may be specified in the BNF – but I'm afraid I don't have time to check every drug in every patient with CKD3 or above.

From Dr Mary Hawking, Dunstable, Bedfordshire

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say